PSS10 Cost- Effectiveness of Ranibizumab in Patients with Neovascular Wet Age-Related Macular Degeneration (Namd) at the Mexican Social Security System (Imss)
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1354
https://www.valueinhealthjournal.com/article/S1098-3015(12)01419-2/fulltext
Title :
PSS10 Cost- Effectiveness of Ranibizumab in Patients with Neovascular Wet Age-Related Macular Degeneration (Namd) at the Mexican Social Security System (Imss)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01419-2&doi=10.1016/j.jval.2012.03.1354
First page :
A251
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
888